Subcutaneous immunoglobulin therapy in a patient with myopathic dropped head syndrome and common variable immunodeficiency

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 4, 2011, Pages 667-670

  Rosato, E ^a   Molinaro, I ^a   Pisarri, S ^a   Salsano, Felice ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Common variable immunodeficiency; Dropped head syndrome; Subcutaneous immunoglobulins; Systemic sclerosis

Indexed keywords

IMMUNOGLOBULIN;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMMON VARIABLE IMMUNODEFICIENCY; DROPPED HEAD SYNDROME; ELECTROMYOGRAPHY; EXTENSOR MUSCLE; FEMALE; FOLLOW UP; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LUNG INFECTION; MUSCLE STRENGTH; MYOPATHY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PULMONARY HYPERTENSION; RECURRENT INFECTION; SYSTEMIC SCLEROSIS;

AGED; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; INFUSIONS, SUBCUTANEOUS; NECK MUSCLES; NEUROMUSCULAR DISEASES; SCLERODERMA, SYSTEMIC;

EID: 84855996852     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Suarez GA, Kelly JJ. The dropped head syndrome. Neurology 1992; 42:1625-27.
2. Kocaaga Z, Bal S, Turan Y, Gurgan A, Esmeli F. Camptocormia and dropped head syndrome as a clinic picture of myotonic myopathy. Joint Bone Spine 2008; 75:730-33.
3. Rosato E, Rossi C, Salsano F. Dropped head syndrome and systemic sclerosis. Joint Bone Spine 2009; 76:301-3
4. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1998; 15:202-5.
5. Denton CP, Humbert M, Rubin L, Black CM. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. Ann Rheum Dis 2006; 65:1336-40. (Pubitemid 44620443)
6. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies: representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93:190-97.
7. Berger M. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin North Am 2008; 28:413-37. (Pubitemid 351522414)
8. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23:581-90.
9. Berger M. Subcutaneous immunoglobulin replacement in primary immunodeficiencies. Clin Immunol 2004; 112:1-7. (Pubitemid 38781052)
10. Rose MR, Levin K, Griggs R. The dropped head plus Syndrome: quantitation of response to corticosteroids. Muscle Nerve 1999; 22:115-18. (Pubitemid 28564046)
11. Dominick J, Sheean G, Schleimer J, Wixom C. Response of the dropped head/bent spine syndrome to treatment with intravenous immunoglobulin. Muscle Nerve 2006; 33:824-26. (Pubitemid 43856802)
12. Biran I, Cohen O, Diment J, Peyser A, Bahnof R, Steiner I. Focal, steroid responsive myositis causing dropped head syndrome. Muscle Nerve 1999; 22:769-71. (Pubitemid 29256847)
13. Deane S, Selmi C, Naguwa SM, Teuber SS, Gershwin ME. Common variable immunodeficiency: etiological and treatment issues. Int Arch Allergy Immunol. 2009; 150:311-24.
14. Moore ML, Quinn JM. Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century. Ann Allergy Asthma Immunol 2008; 101:114-21.
15. Cooper N. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia. Hematol Oncol Clin North Am 2009; 23:1317-27.
16. van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC. IVIG treatment and prognosis in Guillain-Barré syndrome. J Clin Immunol 2010; 30(S):74-78.
17. Luzi G, Bongiorno F, Paparo Barbara S, Bruno G. Intravenous IgG: biological modulating molecules. J Biol Regul Homeost Agents 2009; 23:1-9.
18. Gomard-Mennesson E, Landron C, Dauphin C, et al. Kawasaki disease in adults: report of 10 cases. Medicine (Baltimore) 2010; 89:149-58.
19. Garcin B, Lenglet T, Dubourg O, Mesnage V, Levy R. Dropped head syndrome as a presenting sign of scleromyositis. J Neurol Sci 2010; 292:101-3.
20. Ueda T, Kanda F, Kobessho H, Hamaguchi H, Motomura M. "Dropped head syndrome" caused by Lambert-Eaton myasthenic syndrome. Muscle Nerve 2009; 40:134-36.
21. Yaguchi H, Takei A, Honma S, Yamashita I, Doi S, Hamada T. Dropped head sign as the only symptom of myasthenia gravis. Intern Med 2007; 46:743-45.